drugset / Trial / NCT00881634
To Demonstrate the Relative Bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg Extended Release (ER) Tablets Under Fed Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
To demonstrate the relative bioavailability of Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride 5 mg/120 mg ER tablets under fed conditions.
Timeline
- Start
- 2005-06
- Primary completion
- 2005-07
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cetirizine | Other / unclassified | 5 mg | — |
| Comparator | Pseudoephedrine | Small molecule | 120 mg | — |